ACVR1 and fibrodysplasia ossificans progressiva: Considering the established role of ALK2-related signaling in FOP, diffuse intrinsic pontine glioma and other pathologies, the persisting quest for ALK2 inhibitor advancement necessitates their validation in disease-relevant models [23].